BCRX EBITDA | BIOCRYST PHARMACEUTICALS, INC.

BIOCRYST PHARMACEUTICALS, INC. (BCRX) EBITDA

2026-06-30: Basis Reported; EBITDA (m); Operating income $98.47M; Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA (m); Operating income -$701.60M; Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA $260.78M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA $29.93M*; Operating income $29.59M; Depreciation and amortization $335.00K*.

Complete source-backed ebitda history.

Available history: 2010-12-31 to 2025-12-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	(m)	$98.47M	(m)	(m)	(m)	(m)	$104.34M*	$3.84M	$51.97M	$63.98M	$1.08M
2026-03-31	Reported	(m)	-$701.60M	(m)	(m)	(m)	(m)	-$61.79M	$5.38M	$60.32M	$94.55M	$1.00M
2025-12-31	Reported	$260.78M	(m)	(m)	(m)	64.14%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	$29.93M*	$29.59M	$335.00K*	(m)	(m)	(m)	$41.62M*	$2.19M	$44.60M	$83.01M	-$769.00K
2025-06-30	Reported	$30.11M*	$29.79M	$329.00K*	(m)	(m)	(m)	$41.30M*	$2.80M	$43.39M	$87.38M	$1.40M
2025-03-31	Reported	$21.56M	(m)	(m)	(m)	14.81%	(m)	-$27.52M	$4.57M	$37.27M	$82.47M	$726.00K
2024-12-31	Reported	-$4.2M	(m)	(m)	(m)	-3.19%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	$8.00M*	$7.69M	$311.00K*	(m)	(m)	(m)	$8.24M*	$3.21M	$41.08M	$65.10M	$586.00K
2024-06-30	Reported	$9.08M*	$8.76M	$320.00K*	(m)	(m)	(m)	-$1.37M*	$1.70M	$37.62M	$61.25M	$172.00K
2024-03-31	Reported	-$14.18M	(m)	(m)	(m)	-15.29%	(m)	-$53.68M	$1.26M	$46.49M	$59.49M	$365.00K
2023-12-31	Reported	-$42.25M	(m)	(m)	(m)	-45.23%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	-$11.50M*	-$11.92M	$420.00K*	(m)	(m)	(m)	-$19.90M*	$1.10M	$46.88M	$50.65M	$330.00K
2023-06-30	Reported	-$20.30M*	-$20.70M	$407.00K*	(m)	(m)	(m)	-$18.81M*	$894.00K	$51.25M	$51.00M	$740.00K
2023-03-31	Reported	-$28.01M	(m)	(m)	(m)	-40.73%	(m)	-$47.51M	$931.00K	$48.39M	$47.87M	$671.00K
2022-12-31	Reported	-$45.92M	(m)	(m)	(m)	-57.72%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	-$17.06M*	-$17.45M	$389.00K*	(m)	(m)	(m)	-$32.44M*	$3.54M	$52.74M	$36.92M	$1.52M
2022-06-30	Reported	-$34.39M*	-$34.72M	$335.00K*	(m)	(m)	(m)	-$27.76M*	$246.00K	$61.99M	$38.02M	$856.00K
2022-03-31	Reported	-$49.64M	(m)	(m)	(m)	-99.43%	(m)	-$77.80M	$236.00K	$65.36M	$34.28M	$279.00K
2021-12-31	Reported	-$52.01M	(m)	(m)	(m)	-110.28%	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	-$44.35M*	-$44.58M	$229.00K*	(m)	(m)	(m)	-$23.28M*	$591.00K	$49.97M	$34.99M	$0.00
2021-06-30	Reported	-$29.38M*	-$29.58M	$199.00K*	(m)	(m)	(m)	-$25.41M*	$297.00K	$52.87M	$26.32M	$0.00
2021-03-31	Reported	-$51.2M	(m)	(m)	(m)	-268.63%	(m)	-$61.01M	$5.92M	$42.44M	$22.11M	$0.00
2020-12-31	Reported	-$52.23M	(m)	(m)	(m)	-1300.42%	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	-$42.70M*	-$42.86M	$167.00K*	(m)	(m)	(m)	-$38.26M*	$1.52M	$30.25M	$17.20M	(m)
2020-06-30	Reported	-$38.33M*	-$38.51M	$183.00K*	(m)	(m)	(m)	-$31.04M*	$0.00	$27.50M	$13.88M	(m)
2020-03-31	Reported	-$40.76M	(m)	(m)	(m)	-845.12%	(m)	-$23.28M	$0.00	$29.87M	$15.87M	(m)
2019-12-31	Reported	$76,000.00	(m)	(m)	(m)	0.19%	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	-$34.92M*	-$35.10M	$182.00K*	(m)	(m)	(m)	-$27.64M*	$0.00	$25.12M	$11.73M	(m)
2019-06-30	Reported	-$34.74M*	-$34.92M	$181.00K*	(m)	(m)	(m)	-$24.50M*	$0.00	$27.68M	$8.66M	(m)
2019-03-31	Reported	-$29.15M	(m)	(m)	(m)	-495.23%	(m)	-$27.00M	$1.40M	$27.49M	$6.24M	(m)
2018-12-31	Reported	-$25.06M	(m)	(m)	(m)	-918.43%	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	-$28.30M*	-$28.49M	$195.00K*	(m)	(m)	(m)	-$35.03M*	(m)	$22.01M	$7.92M	(m)
2018-06-30	Reported	-$18.06M*	-$18.25M	$191.00K*	(m)	(m)	(m)	-$13.89M*	(m)	$21.01M	$9.49M	(m)
2018-03-31	Reported	-$22.03M	(m)	(m)	(m)	-554.02%	(m)	-$19.65M	(m)	$18.44M	$7.61M	(m)
2017-12-31	Reported	-$17.68M	(m)	(m)	(m)	-454.47%	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	-$13.17M*	-$13.35M	$178.00K*	(m)	(m)	(m)	-$12.43M*	$1.14M	$17.51M	$3.34M	(m)
2017-06-30	Reported	-$15.34M*	-$15.52M	$172.00K*	(m)	(m)	(m)	-$9.67M*	(m)	$15.76M	$2.83M	(m)
2017-03-31	Reported	-$10.51M	(m)	(m)	(m)	-111.40%	(m)	-$8.53M	(m)	$16.77M	$3.06M	(m)
2016-12-31	Reported	-$8.02M	(m)	(m)	(m)	-89.24%	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	-$9.07M*	-$9.24M	$175.00K*	(m)	(m)	(m)	(m)	(m)	$14.11M	$2.76M	(m)
2016-06-30	Reported	-$12.04M*	-$12.13M	$89.00K*	(m)	(m)	(m)	(m)	(m)	$14.17M	$2.72M	(m)
2016-03-31	Reported	-$19M	(m)	(m)	(m)	-394.21%	(m)	(m)	(m)	$20.58M	$3.21M	(m)
2015-12-31	Reported	-$17.15M	(m)	(m)	(m)	-372.69%	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	-$13.12M*	-$13.16M	$43.00K*	(m)	(m)	(m)	(m)	(m)	$20.07M	$2.73M	(m)
2015-06-30	Reported	$5.39M*	$5.34M	$49.00K*	(m)	(m)	(m)	(m)	(m)	$16.52M	$3.53M	(m)
2015-03-31	Reported	-$14.39M	(m)	(m)	(m)	-210.74%	(m)	(m)	(m)	$17.12M	$4.06M	(m)
2014-12-31	Reported	-$15.12M	(m)	(m)	(m)	-277.56%	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	-$11.57M*	-$11.61M	$40.00K*	(m)	(m)	(m)	-$8.60M*	(m)	$13.04M	(m)	(m)
2014-06-30	Reported	-$11.57M*	-$11.62M	$44.00K*	(m)	(m)	(m)	-$7.10M*	(m)	$11.07M	(m)	(m)
2014-03-31	Reported	-$7.33M	(m)	(m)	(m)	-212.06%	(m)	-$8.96M	(m)	$9.18M	(m)	(m)
2013-12-31	Reported	-$6.28M	(m)	(m)	(m)	-59.40%	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	-$6.86M*	-$6.92M	$64.00K*	(m)	(m)	(m)	-$7.92M*	(m)	$7.74M	(m)	(m)
2013-06-30	Reported	-$12.06M*	-$12.14M	$86.00K*	(m)	(m)	(m)	-$2.90M*	(m)	$11.53M	(m)	(m)
2013-03-31	Reported	-$5.22M	(m)	(m)	(m)	-146.85%	(m)	-$11.20M	(m)	$7.21M	(m)	(m)
2012-12-31	Reported	-$10.53M	(m)	(m)	(m)	-256.72%	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Reported	-$7.88M*	-$8.02M	$136.00K*	(m)	(m)	(m)	-$11.78M*	(m)	$12.07M	(m)	(m)
2012-06-30	Reported	-$10.02M*	-$10.18M	$157.00K*	(m)	(m)	(m)	-$6.34M*	(m)	$12.78M	(m)	(m)
2012-03-31	Reported	-$4.83M	(m)	(m)	(m)	-39.55%	(m)	-$12.25M	(m)	$15.53M	(m)	(m)
2011-12-31	Reported	-$10.79M	(m)	(m)	(m)	-206.47%	(m)	(m)	(m)	(m)	(m)	(m)
2011-09-30	Reported	-$12.62M*	-$12.80M	$185.00K*	(m)	(m)	(m)	-$10.47M*	(m)	$15.10M	(m)	(m)
2011-06-30	Reported	(m)	-$14.24M	(m)	(m)	(m)	(m)	-$3.47M*	(m)	$14.44M	(m)	(m)
2011-03-31	Reported	(m)	-$11.50M	(m)	(m)	(m)	(m)	-$14.33M	(m)	$13.40M	(m)	(m)
2010-12-31	Reported	-$9.14M	(m)	(m)	(m)	-54.74%	(m)	(m)	(m)	(m)	(m)	(m)
2010-09-30	Reported	-$10.68M*	-$10.99M	$308.00K*	(m)	(m)	(m)	-$9.23M*	$0.00*	$19.20M	(m)	(m)
2010-06-30	Reported	(m)	-$10.33M	(m)	(m)	(m)	(m)	(m)	(m)	$14.74M	(m)	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	$342.38M	(m)	(m)	(m)	39.14%	(m)	$347.37M	$19.07M	$166.13M	$348.65M	$3.53M
2024-12-31	Reported	-$1.3M	(m)	(m)	(m)	-0.29%	(m)	-$52.02M	$12.27M	$174.64M	$266.35M	$1.93M
2023-12-31	Reported	-$102.05M	(m)	(m)	(m)	-30.79%	(m)	-$95.14M	$4.48M	$216.57M	$214.07M	$310.00K
2022-12-31	Reported	-$147M	(m)	(m)	(m)	-54.28%	(m)	-$161.85M	$6.41M	$253.30M	$159.37M	$2.73M
2021-12-31	Reported	-$176.94M	(m)	(m)	(m)	-112.58%	(m)	-$142.16M	$7.23M	$208.81M	$118.82M	$2.25M
2020-12-31	Reported	-$174.01M	(m)	(m)	(m)	-976.92%	(m)	-$135.11M	$1.55M	$122.96M	$67.93M	$0.00
2019-12-31	Reported	-$98.73M	(m)	(m)	(m)	-202.17%	$343.00K	-$89.58M	$3.73M	$107.07M	$37.12M	$0.00
2018-12-31	Reported	-$93.45M	(m)	(m)	(m)	-452.48%	$366.00K	-$92.56M	(m)	$84.89M	$29.51M	$0.00
2017-12-31	Reported	-$56.71M	(m)	(m)	(m)	-225.15%	$328.00K	-$41.14M	$1.14M	$66.96M	$13.93M	$0.00
2016-12-31	Reported	-$48.12M	(m)	(m)	(m)	-182.61%	(m)	-$53.44M	$2.30M	$61.01M	$11.25M	$0.00
2015-12-31	Reported	-$39.26M	(m)	(m)	(m)	-81.36%	(m)	-$13.12M	(m)	$72.76M	$13.05M	$0.00
2014-12-31	Reported	-$45.59M	(m)	(m)	(m)	-335.05%	(m)	(m)	(m)	$51.80M	$7.46M	$17.31M
2013-12-31	Reported	-$30.41M	(m)	(m)	(m)	-175.48%	(m)	-$26.53M	(m)	$41.94M	$6.01M	$8.57M
2012-12-31	Reported	-$33.26M	(m)	(m)	(m)	-126.50%	(m)	-$37.40M	(m)	$49.16M	(m)	$7.00M
2011-12-31	Reported	-$48.7M	(m)	(m)	(m)	-247.93%	(m)	-$32.25M	(m)	$57.25M	(m)	(m)
2010-12-31	Reported	-$32.09M	(m)	(m)	(m)	-51.44%	(m)	-$28.55M	$86.00K	$83.90M	(m)	(m)
2009-12-31	Reported	(m)	-$13.74M	(m)	(m)	(m)	(m)	-$16.22M	$4.54M	$73.66M	(m)	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
ADMA BIOLOGICS, INC. (ADMA)	United States	$2.131B	11.16
Kodiak Sciences Inc. (KOD)	United States	$2.090B	-10.12
RECURSION PHARMACEUTICALS, INC. (RXRX)	United States	$2.080B	-3.78
Vericel Corp (VCEL)	United States	$2.011B	93.97
Greenland Mines Ltd (GRML)	United States	$2.362B
Vir Biotechnology, Inc. (VIR)	United States	$1.814B	-6.85
Beam Therapeutics Inc. (BEAM)	United States	$2.549B	-41.51
NOVAVAX INC (NVAX)	United States	$1.748B	-6.26
Hemab Therapeutics Holdings, Inc. (COAG)	United States	$1.672B
Immunocore Holdings plc (IMCR)		$1.613B	-90.43